Harbour Investments’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7 | Sell |
1
-1
| -50% | -$7 | ﹤0.01% | 3590 |
|
|
2025
Q1 | $16 | Buy |
2
+1
| +100% | +$8 | ﹤0.01% | 3527 |
|
|
2024
Q4 | $12 | Hold |
1
| – | – | ﹤0.01% | 3467 |
|
|
2024
Q3 | $86 | Hold |
1
| – | – | ﹤0.01% | 3322 |
|
|
2024
Q2 | $100 | Hold |
1
| – | – | ﹤0.01% | 3205 |
|
|
2024
Q1 | $159 | Hold |
1
| – | – | ﹤0.01% | 3127 |
|
|
2023
Q4 | $111 | Hold |
1
| – | – | ﹤0.01% | 3041 |
|
|
2023
Q3 | $106 | Hold |
1
| – | – | ﹤0.01% | 2922 |
|
|
2023
Q2 | $78 | Hold |
1
| – | – | ﹤0.01% | 2967 |
|
|
2023
Q1 | $57 | Hold |
1
| – | – | ﹤0.01% | 2950 |
|
|
2022
Q4 | $68 | Buy |
+1
| New | +$68 | ﹤0.01% | 2944 |
|
|
2021
Q4 | $0 | Sell |
1
-59
| -98% | – | ﹤0.01% | 2804 |
|
|
2021
Q3 | $17K | Buy |
60
+34
| +131% | +$9.63K | ﹤0.01% | 2372 |
|
|
2021
Q2 | $9K | Buy |
26
+3
| +13% | +$1.04K | ﹤0.01% | 2783 |
|
|
2021
Q1 | $11K | Buy |
+23
| New | +$11K | ﹤0.01% | 2543 |
|